Recent patent applications in antibody fragments

  • Published 2009 in Nature Biotechnology


WO 2008118356 A new CD154 binding protein and related antibody useful for diagnosing and treating a human condition, disorder or disease mediated in whole or in part by CD40 signaling (e.g., immune, autoimmune or inflammatory response). Biogen Idec (Cambridge, MA, USA), UCB Pharma (Brussels) Adams R, Brown DT, Burkly LC, Ferrant-Orgettas JL, Garber EA, Hsu Y, Popplewell AG, Robinson MK, Shock A, Su L, Taylor FR, Tyson KL 3/22/2007 10/2/2008

DOI: 10.1038/nbt0109-41

Cite this paper

@article{2009RecentPA, title={Recent patent applications in antibody fragments}, author={}, journal={Nature Biotechnology}, year={2009}, volume={27}, pages={41-41} }